Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Toric Contact Lenses
1 other identifier
interventional
92
1 country
7
Brief Summary
The primary objective of this study is to evaluate the axis orientation of LID226397 toric contact lenses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2023
Shorter than P25 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2023
CompletedFirst Posted
Study publicly available on registry
July 25, 2023
CompletedStudy Start
First participant enrolled
August 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 23, 2023
CompletedResults Posted
Study results publicly available
November 29, 2024
CompletedNovember 29, 2024
October 1, 2024
2 months
July 13, 2023
October 15, 2024
October 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of Lenses With Axis Orientation Within Plus or Minus 30 Degrees From the Intended Axis at 10 Minutes After Lens Insertion
The investigator will view the contact lens through a slit lamp (biomicroscope) and record the axis orientation (-179° to +180°) as the number of degrees away from the ideal location (90° axis) either positive or negative depending on the direction (nasal \[+\] or temporal \[-\]). No hypothesis testing was prespecified for this endpoint.
Day 1 Dispense, 10 minutes after lens insertion, for each wear period. Each wear period is approximately 14 days according to randomization assignment.
Study Arms (2)
LID226397, then AOfAHP
OTHERSerafilcon A toric contact lenses worn in Period 1, with senofilcon A toric contact lenses worn in Period 2. Each product will be worn bilaterally (in both eyes) during waking hours for approximately 14 days. CLEAR CARE will be used for nightly contact lens cleaning and disinfection.
AOfAHP, then LID226397
OTHERSenofilcon A toric contact lenses worn in Period 1, with serafilcon A toric contact lenses worn in Period 2. Each product will be worn bilaterally (in both eyes) during waking hours for approximately 14 days. CLEAR CARE will be used for nightly contact lens cleaning and disinfection.
Interventions
Silicone hydrogel contact lenses for the optical correction of refractive ametropia (myopia or hyperopia with astigmatism)
Silicone hydrogel contact lenses for the optical correction of refractive ametropia (myopia or hyperopia with astigmatism)
Hydrogen peroxide-based contact lens cleaning and disinfecting solution
Eligibility Criteria
You may qualify if:
- Successful wearers of any commercial soft toric contact lenses (except AOfAHP and daily disposable lenses) in both eyes with at least 3 months wearing experience, with a minimum wearing time of 5 days per week and 10 hours per day.
- Able to be fit with and wear contact lenses within the available range of sphere \& cylinder power and axes.
- Best corrected distance visual acuity greater than or equal to 20/25 Snellen (0.10 logMAR) in each eye as determined by manifest refraction at screening.
You may not qualify if:
- Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.
- Habitual AOfAHP contact lens wearers and habitual daily disposable lens wearers (worn within last 3 months).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alcon Researchlead
Study Sites (7)
Dr. Elsa Pao, OD
Oakland, California, 94607, United States
Pacific Rims Optometry
San Francisco, California, 94127, United States
Drs. Giedd, P.A.
Maitland, Florida, 32751, United States
Vision Health Institute
Orlando, Florida, 32803, United States
Franklin Park Eye Center, PC
Franklin Park, Illinois, 60131, United States
ProCare Vision Centers, Inc.
Granville, Ohio, 43023, United States
Optometry Group, PLLC
Memphis, Tennessee, 38111, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sr. Clinical Project Lead, Vision Care
- Organization
- Alcon Research, LLC
Study Officials
- STUDY DIRECTOR
Clinical Trial Lead, CRD Vision Care
Alcon Research, LLC
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2023
First Posted
July 25, 2023
Study Start
August 14, 2023
Primary Completion
October 23, 2023
Study Completion
October 23, 2023
Last Updated
November 29, 2024
Results First Posted
November 29, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share